Search Results - "Mey, V"

Synergistic interaction between PPAR ligands and salbutamol on human bronchial smooth muscle cell proliferation by Fogli, S, Stefanelli, F, Picchianti, L, Del Re, M, Mey, V, Bardelli, C, Danesi, R, Breschi, MC

“…Background and Purpose An important objective in asthma therapy is to prevent the accelerated growth of airway smooth muscle cells which leads to hyperplasia…”
Get full text

Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma by BENGALA, C, GUARNERI, V, RICCI, S, MOSCA, F, DEL TACCA, M, CONTE, P. F, GIOVANNETTI, E, LENCIONI, M, FONTANA, E, MEY, V, FONTANA, A, BOGGI, U, DEL CHIARO, M, DANESI, R

“…This study aimed to define the maximum-tolerated dose (MTD) of fixed dose rate (FDR) of gemcitabine (2'-2'-difluorodeoxycitidine) infusion with circulating…”
Get full text

In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients by MEY, V, GIOVANNETTI, E, DE BRAUD, F, NANNIZZI, S, CURIGLIANO, G, VERWEIJ, F, DE COBELLI, O, PECE, S, DEL TACCA, M, DANESI, R

“…The present study was performed to investigate the capability of gemcitabine and pemetrexed to synergistically interact with respect to cytotoxicity and…”
Get full text

Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile by GIOVANNETTI, E, MEY, V, DANESI, R, BASOLO, F, BARACHINI, S, DERI, M, DEL TACCA, M

“…The pyrimidine analogue gemcitabine is an established effective agent in the treatment of non-small-cell lung cancer (NSCLC). The present study investigates…”
Get full text

In vitro studies on gemcitabine combinations with other antiblastics by Giovannetti, E., Danesi, R., Mey, V., Nannizzi, S., Pasqualetti, G., Del Tacca, M.

“…The use of gemcitabine in combination with chemotherapeutic agents, including cisplatin, pemetrexed and taxanes, is characterized by the enhancement of their…”
Get full text

Preclinical tests for cerebral stroke by Zini, M. F., Pisanti, N., Biasci, E., Podda, A., Mey, V., Piras, F., L'Abbate, G. L., Marini, S., Fratta, D., Bonaretti, S., Trasciatti, S.

“…Stroke is the second single highest cause of death in Europe. The low reliability of animal models in replicating the human disease is one of the most serious…”
Get full text

Comparison of health-seeking behaviour between poor and better-off people after health sector reform in Cambodia by Yanagisawa, S, Mey, V, Wakai, S

“…This study compared health-seeking behaviour between poor and better-off people after health sector reform in Cambodia. The survey was conducted in the Prek…”
Get full text

Induction of gemcitabine (GCB)-related genes by pemetrexed (MTA): Assessment of the best time interval between MTA and GCB administration by De Pas, T. M., Danesi, R., Toffalorio, F., Milani, A., Giovannetti, E., Mey, V., Nannizzi, S., Pelosi, G., Manzotti, M., de Braud, F.

“…Abstract only 14145 Background: Both MTA and GCB are active drugs in non-small cell lung cancer (NSCLC). Many molecular events induced by MTA support the…”
Get full text

Analysis of single nucleotide polymorphisms (SNPs) of cytidine deaminase (CDA) and xeroderma pigmentosum group D (XPD) genes for the prediction of clinical response to gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC) patients by Vasile, E., Giovannetti, E., Tibaldi, C., Mey, V., Nannizzi, S., Landi, L., Stasi, I., Danesi, R., Del Tacca, M., Falcone, A.

“…Abstract only 7219 Background: Detection of genomic differences predictive of drug response may allow to customize chemotherapy to the characteristics of…”
Get full text

610 POSTER Synergistic cytotoxicity, inhibition of Akt and c-Kit phosphorylation and modulation of gene expression by sorafenib and gemcitabine in human pancreatic cancer cells by Danesi, R., Giovannetti, E., Nannizzi, S., Mey, V., Ricciardi, S., Giazotto, C., Tacca, M. Del

Get full text

HSD99 Pharmacist-Led Interventions for Reducing Health Disparities: A Systematic Review by Mey, SV, Patel, S, Cordone, CN, Lukman, G, Sung, JH, Wang, A, Chan, A, Cadiz, CL, Hurley-Kim, K, Wisseh, C, Knox, E, Lee, JYC, Ozaki, A

Get full text

Silicosis in the coal mining industry by MEY, A V

Get more information

Silicosis by MEY, A V M

Get more information

Report on silicosis conference of the Netherlands Medical Association for Pulmonary Disease and Tuberculosis by MEY, A V M

Get more information

In memoriam Dr. Mr. V.F.J.A.J. van den Brekel by Mey, A V, Muntendam, P

Get more information

Pneumoconiosis by MEY, A V

Get more information

Silikose und Siliko-tuberkulose in Holland by MEY, A V

Get more information

The significance of asthmatic factors in chest pains in mine workers by ORIE, N G, MEY, A V

Get more information

Nepos by MEY, H. W. V. D.

Get full text

Synthesis and turnover of beta2-microglobulin in Ad12-transformed cells defective in assembly and transport of class I major histocompatibility complex molecules by Mey-Tal, S V, Schechter, C, Ehrlich, R

“…In primary embryonal fibroblasts from transgenic mice expressing H-2 genes and a miniature swine class I transgene (PD1), transformation with the highly…”
Get full text